Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Akeso Biopharma

Explore full profile

A clinical-stage biopharmaceutical company committed to in-house discovery, development and commercialization of first-in-class and best-in-class therapies

Zhongshan, ChinaFounded 2012Biotech & Life Sciences
Valuation $9.82B Market cap · Aug/2026
Revenue $420M Latest reported FY

At a glance

Status
Listed
Founded
2012
Headquarters
Zhongshan, China
Listing
IPO 2020
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom
News
News Akeso raises $249M in discounted share placing Oct 13, 2026

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later4 investors entered at this stage

  • Ally Bridge Group
  • ShenZhen GTJA Investment Group
  • Loyal Valley Capital
  • Sino Biopharmaceutical

Talent

Book a demo to see the people
Employees mapped 119 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 22 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Zhongshan HQ
Book a demo for the full country breakdown
Web traffic by country
73K monthly visits
across markets
🇨🇳 China74.1%
🇺🇸 United States7.7%
🇨🇦 Canada3.3%
🏳️ Korea3.3%
🏳️ Republic of2.6%
Top 5 markets shown

Patents

Estimated portfolio value
$59M

101 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Akeso Biopharma was the backer or acquirer, 2025–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

1 deals across Akeso Biopharma's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Akeso Biopharma's portfolio, mapped.

        Stage
        Period
        1 of 1 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Akeso Biopharma on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Akeso Biopharma on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles